Covestor
VERA icon

Covestor’s Vera Therapeutics VERA Stock Holding History

Covestor’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
9
-6
-40% -$210 ﹤0.01% 2869
2026
Q2 		$1K Buy
15
+11
+275% +$410 ﹤0.01% 2377
2026
Q1 		$0 Hold
4
– – ﹤0.01% 2808
2025
Q4 		$0 Hold
4
– – ﹤0.01% 2773
2025
Q3 		$0 Hold
4
– – ﹤0.01% 2812
2025
Q2 		$0 Hold
4
– – ﹤0.01% 2792
2025
Q1 		$0 Buy
4
+1
+33% +$32 ﹤0.01% 2764
2024
Q4 		$0 Buy
3
+1
+50% +$44 ﹤0.01% 2777
2024
Q3 		$0 Sell
2
-1
-33% -$38 ﹤0.01% 2812
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2796
2024
Q1 		$0 Buy
+3
New +$107 ﹤0.01% 2785

Other funds holding VERA

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Covestor's VERA Position: Q3 2026 in Review

Covestor reduced its Vera Therapeutics (VERA) stake by 40% in Q3 2026, selling an estimated $210 and leaving 9 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2869.

Covestor first reported a position in VERA in Q1 2024 and has held it in 11 quarters since. The position peaked at $1K in Q2 2026. 73 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Covestor held 9 shares of Vera Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 6 Vera Therapeutics shares in Q3 2026, an estimated $210.
  • Vera Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2869 holding.
  • Covestor first reported a position in Vera Therapeutics in Q1 2024 and has held it in 11 quarters since.
  • Covestor's Vera Therapeutics position peaked at $1K in Q2 2026.
  • 73 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.